265 related articles for article (PubMed ID: 11500939)
1. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
Scalia P; Heart E; Comai L; Vigneri R; Sung CK
J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).
Dickson LM; Lingohr MK; McCuaig J; Hugl SR; Snow L; Kahn BB; Myers MG; Rhodes CJ
J Biol Chem; 2001 Jun; 276(24):21110-20. PubMed ID: 11274216
[TBL] [Abstract][Full Text] [Related]
3. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
[TBL] [Abstract][Full Text] [Related]
4. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
6. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
8. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.
Cross DA; Alessi DR; Vandenheede JR; McDowell HE; Hundal HS; Cohen P
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):21-6. PubMed ID: 7945242
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
11. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.
Mai L; Jope RS; Li X
J Neurochem; 2002 Jul; 82(1):75-83. PubMed ID: 12091467
[TBL] [Abstract][Full Text] [Related]
12. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
14. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.
Miele C; Rochford JJ; Filippa N; Giorgetti-Peraldi S; Van Obberghen E
J Biol Chem; 2000 Jul; 275(28):21695-702. PubMed ID: 10777488
[TBL] [Abstract][Full Text] [Related]
15. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells.
Syed NA; Khandelwal RL
Mol Cell Biochem; 2000 Aug; 211(1-2):123-36. PubMed ID: 11055555
[TBL] [Abstract][Full Text] [Related]
17. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
Mehrhof FB; Müller FU; Bergmann MW; Li P; Wang Y; Schmitz W; Dietz R; von Harsdorf R
Circulation; 2001 Oct; 104(17):2088-94. PubMed ID: 11673351
[TBL] [Abstract][Full Text] [Related]
18. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
[TBL] [Abstract][Full Text] [Related]
19. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition by hGRB10zeta of insulin-induced glycogen synthase activation: evidence for a novel signaling pathway.
Mounier C; Lavoie L; Dumas V; Mohammad-Ali K; Wu J; Nantel A; Bergeron JJ; Thomas DY; Posner BI
Mol Cell Endocrinol; 2001 Feb; 173(1-2):15-27. PubMed ID: 11223174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
